Phase 2Completed
Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program
Effects of MIB-626 (β-Nicotinamide Mononucleotide) With and Without A High-Intensity Multi-Dimensional Exercise Training Program on Physical Performance, Muscle Bioenergetics, and Neuropsychological Performance in Highly Fit Young Adults
- Sponsor
- Metro International Biotech, LLC (Industry)
- Enrolment
- 124 enrolled
- Conditions
- Healthy
- Interventions
- Investigational Product - MIB 626; Placebo; Standardized, progressive, high intensity, multidimensional exercise; Usual Physical Activity
- Ages
- adults
- Registry
- NCT05878119
From the registry
A single-center, randomized, placebo-controlled study in community dwelling, healthy, regularly exercising, highly physically fit men and women, 19 to 40 years. Eligible participants will be randomized to receive either 1000 mg NMN or placebo twice daily for 10 weeks.
Primary outcomes
- Change in Aerobic capacity from baseline to week 11, identified as VO2 max measured during a standardized increasing work rate treadmill protocol